RxDoctor Payments Data

Alan Kabat

Optometrist · Philadelphia, PANPI 1740354588

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $33,083 of the $49,385 with a category attached, or 67.0%. 17 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 32.4% of the total. Reporting peaked in 2019 at $29,364 and has fallen 99.6% since, to $119 in 2025. Among optometrist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,385in general payments, 2019–2025

Across 93 payments — averaging $531.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$16K
  • Novartis$11K
  • Shire North American Group Inc$9K
  • Kala Pharmaceuticals, Inc.$5K
  • Dompe US, Inc.$3K
  • Quidel Corporation$2K
  • plus $2K from 11 others

What the payments were for

  • Consulting fees$9,68820%
  • Speaking & faculty fees$33,08367%
  • Travel & lodging$4,0508%
  • Food & beverage$2,5445%
  • Gifts$190%

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,385 in reported general payments places this provider in the 95th percentile of 2,165 optometrist providers in Pennsylvania.

See all optometrist providers in Pennsylvania

Other optometrist in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →